ARCHIVES

Virus Studies Approved By DCE Board for $2.5 Mil. In First Year

This article is from The Cancer Letter archive.

Vol. 15 No. 42 | November 3, 1989

Download PDF Visit The Full Archive

Related Articles

Ceritinib Demonstrates 58% ORR, 7-month PFS in ALK+ NSCLC

March 28, 2014

Postdoc Fabricated Results In Published Study, ORI Says.

October 27, 2000

Racial Disparities Persist In Diagnosis Of Advanced Breast Cancer, Colon Cancer

February 26, 2010

Dingell: “Unable To Vouch” For Staff Report On NCI’s Gallo

February 10, 1995

Hood’s ISB Gets $5 Million From Merck, Hires Scientists.

September 1, 2000

Hearing Scheduled To Investigate ImClone’s C225 Development, Stock Trading

June 7, 2002